Cargando…
An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features
SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rare...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616256/ https://www.ncbi.nlm.nih.gov/pubmed/34831006 http://dx.doi.org/10.3390/cancers13225853 |
_version_ | 1784604303350038528 |
---|---|
author | Salem, Ahmed Ebada Zaki, Yehia H. El-Hussieny, Gamal ElNoueam, Khaled I. Shaaban, Akram M. Koppula, Bhasker Rao Bustoros, Mark Salama, Mohamed Elsayes, Khaled M. Morton, Kathryn Covington, Matthew F. |
author_facet | Salem, Ahmed Ebada Zaki, Yehia H. El-Hussieny, Gamal ElNoueam, Khaled I. Shaaban, Akram M. Koppula, Bhasker Rao Bustoros, Mark Salama, Mohamed Elsayes, Khaled M. Morton, Kathryn Covington, Matthew F. |
author_sort | Salem, Ahmed Ebada |
collection | PubMed |
description | SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rarely discussed in the radiology literature. Many of these disorders have distinct clinical and imaging features, overlapping with more common disorders, thus causing a delay in diagnosis and management. Early diagnosis of many of these disorders is key as many of these are potentially treatable because early intervention may be lifesaving. The purpose of this manuscript is to provide guidance for radiologists regarding certain rare variants of B-cell lymphoproliferative disorders, in terms of clinical, histologic, and imaging findings, as well as to incorporate the new and updated terminology of some disorders included within the 4th edition of the WHO classification of lymphoid neoplasm. ABSTRACT: Lymphoproliferative disorders (LPD) are conditions characterized by the uncontrolled proliferation of B or T-cell lines. They encompass a wide spectrum of abnormalities, which may be broadly classified as reactive processes or malignant diseases, such as lymphoma, based on their cellular clonality and clinical behavior. While some of these disorders are rare, they may be encountered sporadically in clinical practice, causing diagnostic dilemmas owing to overlap in their clinical and imaging features with more common disorders. The updated 4th edition WHO classification of lymphoid neoplasms was released in 2016 to incorporate the rapid clinical, pathological, molecular biology and cytogenetic advances of some of these disorders. Despite these updates, very little information is presented in the literature from the radiology perspective. The aim of this article is to familiarize radiologists and other physicians with certain rare variants of B-cell lymphoproliferative disorders with a focus on imaging features of these disorders, as well as to provide an overview of some important updates contained within the new WHO classification of lymphoid neoplasms. |
format | Online Article Text |
id | pubmed-8616256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86162562021-11-26 An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features Salem, Ahmed Ebada Zaki, Yehia H. El-Hussieny, Gamal ElNoueam, Khaled I. Shaaban, Akram M. Koppula, Bhasker Rao Bustoros, Mark Salama, Mohamed Elsayes, Khaled M. Morton, Kathryn Covington, Matthew F. Cancers (Basel) Review SIMPLE SUMMARY: The updated 4th edition WHO classification of lymphoid malignancies released in 2016 contains pivotal new terminology and information that is important for radiologists to understand. In spite of these updates, some lymphoproliferative disorders included in this update have been rarely discussed in the radiology literature. Many of these disorders have distinct clinical and imaging features, overlapping with more common disorders, thus causing a delay in diagnosis and management. Early diagnosis of many of these disorders is key as many of these are potentially treatable because early intervention may be lifesaving. The purpose of this manuscript is to provide guidance for radiologists regarding certain rare variants of B-cell lymphoproliferative disorders, in terms of clinical, histologic, and imaging findings, as well as to incorporate the new and updated terminology of some disorders included within the 4th edition of the WHO classification of lymphoid neoplasm. ABSTRACT: Lymphoproliferative disorders (LPD) are conditions characterized by the uncontrolled proliferation of B or T-cell lines. They encompass a wide spectrum of abnormalities, which may be broadly classified as reactive processes or malignant diseases, such as lymphoma, based on their cellular clonality and clinical behavior. While some of these disorders are rare, they may be encountered sporadically in clinical practice, causing diagnostic dilemmas owing to overlap in their clinical and imaging features with more common disorders. The updated 4th edition WHO classification of lymphoid neoplasms was released in 2016 to incorporate the rapid clinical, pathological, molecular biology and cytogenetic advances of some of these disorders. Despite these updates, very little information is presented in the literature from the radiology perspective. The aim of this article is to familiarize radiologists and other physicians with certain rare variants of B-cell lymphoproliferative disorders with a focus on imaging features of these disorders, as well as to provide an overview of some important updates contained within the new WHO classification of lymphoid neoplasms. MDPI 2021-11-22 /pmc/articles/PMC8616256/ /pubmed/34831006 http://dx.doi.org/10.3390/cancers13225853 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Salem, Ahmed Ebada Zaki, Yehia H. El-Hussieny, Gamal ElNoueam, Khaled I. Shaaban, Akram M. Koppula, Bhasker Rao Bustoros, Mark Salama, Mohamed Elsayes, Khaled M. Morton, Kathryn Covington, Matthew F. An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title | An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title_full | An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title_fullStr | An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title_full_unstemmed | An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title_short | An Overview of Selected Rare B-Cell Lymphoproliferative Disorders: Imaging, Histopathologic, and Clinical Features |
title_sort | overview of selected rare b-cell lymphoproliferative disorders: imaging, histopathologic, and clinical features |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616256/ https://www.ncbi.nlm.nih.gov/pubmed/34831006 http://dx.doi.org/10.3390/cancers13225853 |
work_keys_str_mv | AT salemahmedebada anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT zakiyehiah anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elhussienygamal anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elnoueamkhaledi anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT shaabanakramm anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT koppulabhaskerrao anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT bustorosmark anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT salamamohamed anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elsayeskhaledm anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT mortonkathryn anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT covingtonmatthewf anoverviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT salemahmedebada overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT zakiyehiah overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elhussienygamal overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elnoueamkhaledi overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT shaabanakramm overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT koppulabhaskerrao overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT bustorosmark overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT salamamohamed overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT elsayeskhaledm overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT mortonkathryn overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures AT covingtonmatthewf overviewofselectedrarebcelllymphoproliferativedisordersimaginghistopathologicandclinicalfeatures |